
BERLIN, Feb 3 (Reuters) - Roche ROG.S does not expect a material business impact from the tariffs announced by U.S. President Donald Trump on Mexico, Canada and China at this time, a spokesperson for the Swiss drugs and diagnostics group said on Monday.
"We will continue to monitor the situation," added the spokesperson.